new_0222_0459|ELYM|0|ps_ratio|price_to_book_value|peg_ratio|price|short_interest|dividend_yield|earning_yield|market_cap|pe_ratio|consensus_recommendation|price_target_num_est|price_target|sales_est_1y|sales_est_0y|eps_est_1y|eps_est_0y|ebitda_est_0y|ebitda_est_1y|revenues|ebitda|net_income|price_next_month|price_second_month
new_0222_0459|ELYM|1|Eliem Therapeutics Inc PS Ratio|Eliem Therapeutics Inc Price to Book Value|Eliem Therapeutics Inc PEG Ratio|Eliem Therapeutics Inc Price (USD)|Eliem Therapeutics Inc Short Interest|Eliem Therapeutics Inc Dividend Yield|Eliem Therapeutics Inc Earnings Yield|Eliem Therapeutics Inc Market Cap (USD)|Eliem Therapeutics Inc PE Ratio|Eliem Therapeutics Inc Consensus Recommendation|Eliem Therapeutics Inc Price Target Num Estimates|Eliem Therapeutics Inc Price Target (USD)|Eliem Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Eliem Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Eliem Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Eliem Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Eliem Therapeutics Inc EBITDA Estimates for Current Fiscal Year (USD)|Eliem Therapeutics Inc EBITDA Estimates for Next Fiscal Year (USD)|Eliem Therapeutics Inc Revenue (Quarterly) (USD)|Eliem Therapeutics Inc EBITDA (Quarterly) (USD)|Eliem Therapeutics Inc Net Income (Quarterly) (USD)||
new_0222_0459|ELYM|2|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_price|figure_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_whole_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0459|ELYM|4|quarterly|daily|quarterly|daily|monthly|daily|daily|daily|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0459|ELYM|5||1.4387755102||1.4328358209|15.5454545455|1.4328358209|1.4328358209|1.4328358209||20.375|27.1666666667|27.1666666667|34.75|27.8||||||91.3333333333|91.3333333333||
new_0222_0459|ELYM|6||98||134|11|134|134|134||8|6|6|4|5||||||6|6||
new_0222_0459|ELYM|7|daily|daily|daily|market_daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly||
new_0222_0459|ELYM|20200315||||||||||||||||||||-1.951|-1.916||
new_0222_0459|ELYM|20200615||||||||||||||||||||-1.608|-1.631||
new_0222_0459|ELYM|20200915||||||||||||||||||||-2.259|-2.258||
new_0222_0459|ELYM|20201215||||||||||||||||||||-15.107|-14.863||
new_0222_0459|ELYM|20210315||||||||||||||||||||-6.879|-18.601||
new_0222_0459|ELYM|20210615||||||||||||||||||||-8.707|-8.719||
new_0222_0459|ELYM|20210815||||15.9|130179||-23.526|403.1954||||||||||||||20.63|25.69
new_0222_0459|ELYM|20210915||2.6665||26.9|465495||-13.9057|707.9596||1|3|33.3333||||||||-9.383|-9.615|27.35|17.98
new_0222_0459|ELYM|20211015||2.8889||19.48|705809||-21.5989|510.3624||||||||||||||19.59|17.42
new_0222_0459|ELYM|20211115||2.3536||15.87|676612||-26.5121|415.7829||1|3|33.3333||||||||||16.05|14.39
new_0222_0459|ELYM|20211215||2.0412||13.58|737853||-30.9829|360.6074||||||||||||||11.34|10.46
new_0222_0459|ELYM|20220115||1.6369||10.89|761355||-38.6361|289.1763||1|3|33.3333||||||||||9.51|9.04
new_0222_0459|ELYM|20220215||1.3784||9.17|||-45.883|243.5029||1|3|33.3333||||||||||8.79|8.82